Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Elematec Corporation Forms Business Alliance and Makes Strategic Investment in MEDIROM Healthcare Technologies’ MOTHER Labs
Oct 15, 2024•over 1 year ago
Contract Type
partnership
Description
MEDIROM Healthcare Technologies Inc. announces the formation of a capital and business alliance between its subsidiary MEDIROM MOTHER Labs Inc. and Elematec Corporation. Elematec has agreed to make a strategic investment in MEDIROM MOTHER Labs’ Series A round at a pre-money valuation of 9 billion yen
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months